Dr. Ghassan El-Haddad, M.D.
What this data tells you about Dr. El-Haddad
Dr. Ghassan El-Haddad is a nuclear imaging & therapy physician in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. El-Haddad performed 819 Medicare services across 625 unique beneficiaries.
Between the years covered by Open Payments, Dr. El-Haddad received a total of $41,774 from 37 pharmaceutical and/or device companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear imaging & therapy physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El-Haddad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Radioactive drug therapy through a vein | 179 | $74 | $352 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 146 | $10 | $42 |
| Ultrasonic guidance for blood vessel access | 41 | $12 | $53 |
| Review by radiologist of additional artery image | 39 | $38 | $78 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 38 | $15 | $63 |
| Review by radiologist of ct guidance for needle placement | 37 | $54 | $196 |
| Complex radiation therapy planning | 35 | $137 | $526 |
| Calculation of radiation therapy dose | 35 | $27 | $103 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 34 | $39 | $256 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 34 | $64 | $261 |
| Ultrasonic guidance for needle placement | 30 | $24 | $115 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 25 | $158 | $3,148 |
| Review by radiologist of abdominal artery image | 22 | $77 | $195 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 19 | $117 | $541 |
| Insertion of central venous tube with port (5 years or older) | 19 | $273 | $1,740 |
| Occlusion of growths or obstructed vessels with review by radiologist | 18 | $448 | $2,090 |
| Needle biopsy or removal of surface lymph nodes | 15 | $65 | $243 |
| Needle biopsy of growth of abdominal cavity | 15 | $66 | $305 |
| Radioactive drug therapy through a tube inserted in an artery | 14 | $89 | $417 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 12 | $58 | $258 |
| Needle biopsy of liver through skin | 12 | $71 | $342 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (68%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. El-Haddad is a mixed practice specialist, and consulting-driven industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. El-Haddad experienced with radioactive drug therapy through a vein?
Does Dr. El-Haddad receive payments from pharmaceutical companies?
How do Dr. El-Haddad's costs compare to other nuclear imaging & therapy physicians in Tampa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology